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nary hypertension (PH) is the consequence of left ventricular (LV) diastolic
pressure elevation and/or functional mitral regurgitation. We aimed to eval-
uate determinants and prognostic significance of rest and exercise in HCM. 
Methods and results We included 235 patients referred for clinical work-
up of HCM. Rest pulmonary artery systolic pressure (PASP) was measurable
in 214 (91%) patients (48±16 years, 161 males). A symptom-limited semi-
supine bicycle exercise was carried out in 188 patients. PASP was measurable
during exercise in 108 patients (57%). Resting PH (≥36mmHg) was present in
56 patients (26.2%) and exercise PH (≥60mmHg) in 38 patients (35.2%).
Mutivariate correlates of rest PASP were sinus rhythm (β=–0.15, P=0.021),
LV obstruction tract (LVOT) peak gradient (β=0.22, P=0.001) and left atrial
volume (β=0.39, P<0.0001). Multivariate resting correlates of exercise PASP
were PASP (β=0.28, p=0.001) and mitral regurgitation (MR) grade (β=0.48,
P<0.0001). LVOT peak gradient emerged as an independent correlate of exer-
cise PASP when MR was excluded. Patients with rest PH had a worse event-
free survival at 4 years (24.8±8.8 vs 66.2±5.2%, P<0.0001), survival
without HF (55.6±10.5 vs 81.8±4.3%, P=0.005), and overall survival
(84.2±7.1 vs 97.1±1.7%, P=0.001). Patients with exercise PH had also a worse
event-free survival (47.7±9.5 vs 65.7±7.5%, P=0.007) and a worse survival
without HF (64.1±9.4 vs 83.4±5.5%, P=0.016). By contrast, there was no dif-
ference regarding overall survival (p=0.49).
Conclusion In patients with HCM, the main determinants of rest PH are
sinus rhythm, LVOT peak gradient and left atrium volume. Determinants of
exercise PH are rest PASP, grade of MR and rest LVOT gradient. Rest and
exercise PH predict a poor outcome in HCM.
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Objective Hypertrophic cardiomyopathy (HCM) is a genetic disease with
delayed cardiac expression. Our objective was to characterize global and
regional LV myocardial strain by two-dimensional imaging in sarcomeric
HCM families and hypothesized that early systolic dysfunction, before hyper-
trophic stage, may be diagnosed by this technique.
Methods and results We analyzed 81 adults: HCM patients with LV
hypertrophy (LVH+, n=38), mutation carriers without LV hypertrophy (LVH-
/G+, n=20), and normal control subjects (n=23). We calculated global longi-
tudinal strain (GLS), regional peak longitudinal strain and the Echo/TDI score
(combination of 3 parameters about remodeling and pulse TDI). Age, sex ratio
and body surface area were not significantly different between groups. Max-
imal 2D wall thickness of left ventricle was 10.1±1.6mm in LVH-/G+ and not
different from controls (9.9±1.2mm). We observed that LV GLS was not dif-
ferent in LVH-/G+ as compared to controls (–21.6%±3.2 vs –23.5%±3.3) but
was reduced in HCM patients (–15.3%±4.5) although a normal ejection frac-
tion. Interestingly, regional peak longitudinal strain was similar in LVH-/G+
and controls except antero-septo-basal segment strain that was decreased in
LVH-/G+ as compared to controls (–15.6%±7.2 vs –20.0%±3.9, p=0.025). A
cut-off of –16% for abnormal strain of antero-septo-basal segment identified
LVH-/G+ subjects with a sensitivity of 47% and a specificity of 90%. The
Echo/TDI score was different in LVH-/G+ as compared to controls
(p=0.0008) and sensitivity of previous defined cut-off was 83% for identifica-
tion of LVH-/G+. All LVH-/G+ subjects with abnormal regional strain, except
one, had abnormal Echo/TDI score.
Conclusion We observed that regional longitudinal strain, but not global
strain, was significantly reduced at early stage of HCM. This tool may be
useful for clinical evaluation of relatives in daily practice, but does not pro-
vide significant additional information as compared to the Echo/TDI score.
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Background and objective Pregnancies in women with cardiomyopathies
are considered at high risk for complications. However we lack data to charac-
terize their natural history and to predict the outcome. Our aim was to evaluate
the prevalence and predictors of acute cardiac and obstetrical events in pregnant
women with a cardiomyopathy, excluding peripartum cardiomyopathy.
Methods and results The monocentric retrospective survey includes
43 pregnancies in 36 women with dilated cardiomyopathy (DCM, n=10),
hypertrophic cardiomyopathy (HCM, n=28), arrhythmogenic right ventricular
cardiomyopathy (ARVC, n=3), tachycardia-induced-cardiomyopathy (TCM,
n=1) and non-compacted left ventricle (NCLV, n=1). There were 1 fetal death
(with maternal cardiac death), 10 (23%) preterm deliveries and 11 (26%) low
neonatal birth weights. There were major maternal cardiovascular events in
14 pregnancies including 6 acute heart failures (5 DCM, 1HCM), and 3 car-
diac deaths, which occurred in cases that did not follow our usual multidisci-
plinary protocol (1 pregnancy denial with DCM, 1 undiagnosed HCM, 1 DCM
recognized near term). CARPREG score was predictive of maternal cardiac
events that occurred in 67%, 33% and 25% of pregnancies with CARPREG
scores of 2, 1 and 0 respectively. However major complications (heart failure,
asymptomatic degradation of LVEF, and symptomatic aggravation of pulmo-
nary artery hypertension) occurred in 3 women with no known risk factors.
LV ejection fraction alone, gradient in HCM, ZAHARA or WHO scores were
less discriminant than CARPREG for maternal outcome. 
Conclusion Pregnancy in women with a Cardiomyopathy is a high risk
period for both major cardiac and fetal events. The worst complications
occurred in cases that did not benefit from a multidisciplinary team manage-
ment. The highest rate of events was observed in DCM patients but significant
risk was also associated with HCM. Prediction of risk with CAPREG scoring
is appropriate but need to be improved. 
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Background Heart failure is the leading cause of hospital admissions and
economic burden. In accordance with guidelines, a dedicated heart failure unit
has been created in Bordeaux (France) in May 2011.
Aim Evaluate the impact of a heart failure management unit with ambula-
tory sector on readmission rate and mortality; and identify prognosis parame-
ters at diagnosis and 6 months after.
Methods Descriptive study of mortality and heart-failure-related readmis-
sion rates after a first admission for heart failure, from May 2011 to July 2014
(inclusion stopped in July 2013). Student’s test and Cox’s regression have
been performed.
Results Since the creation of this unit, its activity has been growing by
30% in the first year and 10%, in the second. 421 patients with less than 40%
left ventricular ejection fraction (LVEF) have been included; 181 had been
treated before May 2011 while 240 were news patients treated during the
study. Average age was 57±14 years old and average LVEF was 28%±7%.
